REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Orivas (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: UAB Orivas Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

UAB Orivas is based in Lithuania. The head office is in Vilnius. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on February 09, 2001. It currently has a total number of 19 (2025) employees. From the latest financial highlights, UAB Orivas reported a net sales revenue increase of 5.97% in 2025. UAB Orivas’s net profit margin decreased by 3.25% in 2025.

Headquarters
J. Jasinskio g. 16B
Vilnius; Vilnius county; Postal Code: LT-03163

Contact Details: Purchase the UAB Orivas report to view the information.

Website: https://orivas.lt/

Basic Information
Total Employees:
Purchase the UAB Orivas report to view the information.
Registered Capital:
Purchase the UAB Orivas report to view the information.
Financial Auditors:
Purchase the UAB Orivas report to view the information.
Incorporation Date:
February 09, 2001
Key Executives
Purchase this report to view the information.
Member of the Management Board
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after UAB Orivas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
5.97%
Total Operating Revenue
5.97%
Net Profit/Loss for the Period
-7.32%
Total Equity
-33.83%
Net Profit Margin
-3.25%
Return on Equity (ROE)
26.51%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?